Skip to main content
Premium Trial:

Request an Annual Quote

NIMH To Award $1.5M in FY '07 for Genomics/Phenomics Autism Center

NEW YORK (GenomeWeb News) - The National Institutes of Mental Health is seeking applicants to establish a center for genomic studies of autism.
 
In a request for applications released on Nov. 29, NIMH said it plans to commit at least $1.5 million in fiscal 2007 toward establishing the Center for Genomic and Phenomic Studies on Autism, and said proposed budgets for the first year of research may be as much as $1.25 million.
 
NIMH said it anticipates awarding a single, five-year award under the program.
 
The center will collect data and samples from a diverse range of autistic probands and their relatives to use in interdisciplinary genomic and basic and translational research in neuroscience.
 
It will use NIMH resources from NIH's General Clinical Research Center, including infrastructure, clinical screening expertise, bioinformatics, database management, high-throughput diagnostic assessments, and morphological scanning and clinical trials.
 
The study will require expertise in areas including: high-throughput diagnostic easements using the autism diagnostic review, high-throughput diagnostic assessments and phenotyping, clinical trials, and other relevant skill sets. 
 
NIMH said any individual with the "skills, knowledge and resources to carry out the proposed research" are invited to submit applications.
 
The due date for letters of intent is Dec. 27, and applications must be received by Jan. 26, 2007. NIMH anticipates the study to begin on July 1, 2007.
 
For more information, see the RFA.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.